Mineral metabolism in heart disease
- 1 June 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Nephrology and Hypertension
- Vol. 24 (4), 310-6
- https://doi.org/10.1097/mnh.0000000000000129
Abstract
Strong experimental and clinical evidence points towards a substantial contribution of mineral metabolism disorders to the initiation and progression of cardiovascular disease. Vice versa, recent work suggests that cardiovascular disease may also cause mineral metabolism alterations. Experimental studies suggest that hyperphosphatemia, elevated plasma levels of phosphaturic hormones--parathyroid hormone and fibroblast growth factor-23 (FGF-23)--and hypovitaminosis D exert detrimental effects on vascular tissue and on the myocardium. Accordingly, in longitudinal clinical cohort studies, individuals with high plasma levels of phosphate, parathyroid hormone and FGF-23, and with low vitamin D levels, face worst cardiovascular prognosis.Notably, recent evidence suggests that cardiovascular disease may not only follow but also induce mineral metabolism disorders: severe derangements in mineral metabolism were observed in patients with acute heart failure, who face a tremendous increase in plasma FGF-23. Unfortunately, few prospective studies have been completed hitherto that specifically target components of the mineral metabolism for cardiovascular disease prevention or treatment. A bidirectional interaction exists between mineral metabolism disorders and cardiovascular disease. However, clinical evidence for a cardiovascular benefit of therapeutic interventions into mineral metabolism is outstanding.Keywords
This publication has 34 references indexed in Scilit:
- Serum Phosphorus and Mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect Modification by FastingAmerican Journal of Kidney Diseases, 2014
- High dietary phosphorus intake is associated with all-cause mortality: results from NHANES IIIThe American Journal of Clinical Nutrition, 2014
- 24-Hour Urine Phosphorus Excretion and Mortality and Cardiovascular EventsClinical Journal of the American Society of Nephrology, 2013
- Alkaline Phosphatase, Serum Phosphate, and Incident Cardiovascular Disease and Total Mortality in Older MenArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Mechanistic Insights into Vascular Calcification in CKDJournal of the American Society of Nephrology, 2013
- High phosphate directly affects endothelial function by downregulating annexin IIKidney International, 2013
- Calcium and phosphate impact cardiovascular riskEuropean Heart Journal, 2012
- Phosphate: The new cholesterol? The role of the phosphate axis in non-uremic vascular diseaseAtherosclerosis, 2011
- Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary DiseaseCirculation, 2005
- Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failureKidney International, 2004